Nvision Biomedical Technologies receives FDA clearance for 3D-printed interbody system
Click Here to Manage Email Alerts
Key takeaways:
- Nvision Biomedical Technologies announced FDA clearance of its 3D-printed PEEK interbody system.
- The system is combined with PEEK-OPTIMA polymers from Invibio Biomaterial Solutions.
Nvision Biomedical Technologies announced FDA clearance of its 3D-printed PEEK interbody system made from PEEK-OPTIMA polymers from Invibio Biomaterial Solutions, according to a company press release.
“The combination of solid and highly intricate porous PEEK-OPTIMA structures within the Nvision system allows for potential bone ingrowth to achieve fixation while maintaining the inherent benefits of PEEK-OPTIMA for imaging and bone-like modulus,” John Devine, PhD, managing director of Invibio, said in the release.
According to the release, the 3D-printed PEEK interbody system was co-developed by Nvision and Invibio. The system includes cervical and anterior lumbar interbody fusion (ALIF) spine devices.
“Our partnership with Invibio on this project showcases our commitment to pushing the boundaries of medical device innovation,” Brian Kieser, CPA, CEO of Nvision, said in the release. “This latest FDA clearance builds on a history of successful co-development between Nvision and Invibio, particularly in spine and foot and ankle devices. We are thrilled to introduce the 3D-printed PEEK cervical and ALIF lines, available in various footprints and lordotic angles, and all incorporating the same porous design features aimed at promoting bone ingrowth.”
Read more about
Click Here to Manage Email Alerts